Clinical Advisor | Risk of Alzheimer dementia after androgen deprivation therapy Clinical Advisor A recent retrospective cohort study using data from electronic medical records evaluated the risk of developing Alzheimer dementia after ADT in 16,888 men with prostate cancer, 14.2% of whom were treated with ADT. Men receiving chemotherapy as well as ... |